ACAD CIK: 1070494

Acadia Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.47
FY22:
0.51
FY23:
0.68
FY24:
0.88
FY25:
0.98
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.16
FY22:
−0.22
FY23:
−0.07
FY24:
0.23
FY25:
0.10
(positive)
Change from FY23 to FY25
billions USD
FY21:
–
FY22:
–
FY23:
−0.07
FY24:
–
FY25:
0.12
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.17
FY22:
−0.21
FY23:
−0.05
FY24:
0.26
FY25:
0.14
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.17
FY22:
−0.22
FY23:
−0.06
FY24:
0.23
FY25:
0.39

All amounts in billions USD Data sources:SEC EDGARTwelve Data